CD274 and melanoma: In this study, we evaluated recombinant Brome Mosaic Virus–like particles (BMV-VLPs) as biodegradable nanocarriers for delivering functional siRNA to modulate PD-L1–dependent immune suppression in melanoma and immune cell models.